This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Kiniksa Pharmaceuticals, Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Jianwen Xu
Introduction
Jianwen Xu is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work is characterized by a focus on innovative solutions to complex medical challenges.
Latest Patents
Jianwen Xu holds a patent for "Formulations of Anti-Interleukin 1 Receptor 1 Antibodies." This patent represents a crucial advancement in the treatment of various inflammatory conditions. His innovative approach has the potential to improve patient outcomes significantly.
Career Highlights
Currently, Jianwen Xu is employed at Kiniksa Pharmaceuticals, Ltd., where he continues to push the boundaries of medical research and development. His expertise in antibody formulations has positioned him as a key player in the pharmaceutical industry.
Collaborations
Jianwen Xu collaborates with Ajit D'Souza, leveraging their combined expertise to drive forward innovative projects within their company. Their partnership exemplifies the importance of teamwork in achieving groundbreaking results in research.
Conclusion
Jianwen Xu's contributions to the field of biotechnology through his patent and work at Kiniksa Pharmaceuticals, Ltd. highlight his role as an influential inventor. His ongoing efforts in developing therapeutic solutions continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile